HK1156368A1 - Methods for diagnosing ischemia - Google Patents

Methods for diagnosing ischemia

Info

Publication number
HK1156368A1
HK1156368A1 HK11110696.3A HK11110696A HK1156368A1 HK 1156368 A1 HK1156368 A1 HK 1156368A1 HK 11110696 A HK11110696 A HK 11110696A HK 1156368 A1 HK1156368 A1 HK 1156368A1
Authority
HK
Hong Kong
Prior art keywords
methods
diagnosing ischemia
ischemia
diagnosing
Prior art date
Application number
HK11110696.3A
Other languages
English (en)
Chinese (zh)
Inventor
Huichun Xu
Frank Sharp
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of HK1156368A1 publication Critical patent/HK1156368A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK11110696.3A 2007-05-01 2010-07-26 Methods for diagnosing ischemia HK1156368A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91536607P 2007-05-01 2007-05-01

Publications (1)

Publication Number Publication Date
HK1156368A1 true HK1156368A1 (en) 2012-06-08

Family

ID=39943905

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11110696.3A HK1156368A1 (en) 2007-05-01 2010-07-26 Methods for diagnosing ischemia

Country Status (6)

Country Link
US (3) US20100197518A1 (fr)
EP (2) EP2311981B1 (fr)
CN (1) CN101688245B (fr)
CA (1) CA2685382C (fr)
HK (1) HK1156368A1 (fr)
WO (1) WO2008137465A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2311981B1 (fr) 2007-05-01 2014-09-17 The Regents of The University of California Procédés de diagnostic d'ischémie
CA2804763C (fr) 2010-07-14 2023-01-03 The Regents Of The University Of California Biomarqueurs utilises pour le diagnostic d'accidents ischemiques transitoires
CA2804802C (fr) 2010-07-15 2023-03-07 The Regents Of The University Of California Biomarqueurs utilises pour diagnostiquer un accident vasculaire cerebral et ses causes
JP5832534B2 (ja) * 2010-07-28 2015-12-16 アボット ゲーエムベーハー ウント コー． カーゲー 虚血性脳卒中を検出する方法
US20140086899A1 (en) * 2011-01-28 2014-03-27 Commonwealth Scientific And Industrial Research Organisation Diagnostic and prognostic assay for a condition or event of the vascular system
US20120316076A1 (en) 2011-03-04 2012-12-13 The Regents Of The University Of California Biomarkers for the diagnosis of lacunar stroke
SG2014014559A (en) * 2011-10-17 2014-08-28 Hoffmann La Roche Troponin and bnp based diagnosis of risk patients and cause of stroke
WO2013103781A1 (fr) 2012-01-07 2013-07-11 The Regents Of The University Of California Biomarqueurs permettant de diagnostiquer l'ischémie.
EP2647726A1 (fr) * 2012-04-05 2013-10-09 Universitätsklinikum Freiburg Biomarqueurs cardiovasculaires
US9309485B2 (en) 2013-06-26 2016-04-12 Ecolab USA, Inc. Use of nonionics as rheology modifiers in liquid cleaning solutions
EP3224380A1 (fr) 2014-11-25 2017-10-04 The Broad Institute Inc. Hématopoïèse clonale
WO2016086197A1 (fr) * 2014-11-25 2016-06-02 The Brigham And Women's Hospital, Inc. Méthode d'identification et de traitement d'une personne présentant une prédisposition à souffrir ou souffrant d'une maladie cardiométabolique
CA2992139A1 (fr) * 2015-07-10 2017-01-19 West Virginia University Marqueurs d'accident vasculaire cerebral et de gravite d'accident vasculaire cerebral
CN107904300B (zh) * 2017-12-27 2021-06-08 南京医科大学 一种可预测人冠状动脉粥样硬化性心脏病严重缺血风险的mRNA及其应用
KR102281657B1 (ko) * 2019-12-23 2021-07-26 한림대학교 산학협력단 지연성 허혈 진단을 위한 cdhr5 유전자 과메틸화 마커
KR102281644B1 (ko) * 2019-12-23 2021-07-23 한림대학교 산학협력단 지연성 허혈 진단을 위한 insr 유전자 과메틸화 마커
CN115089715B (zh) * 2022-07-06 2023-06-30 四川大学 Alpk1基因作为中枢神经系统疾病预防或治疗靶点的应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3064A (en) * 1843-05-02 Stove
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US20020115120A1 (en) 1999-01-26 2002-08-22 Millennium Pharmaceuticals, Inc. Novel molecules of the HKID-1-related protein family and uses thereof
WO2002012892A2 (fr) 2000-08-04 2002-02-14 Cis Biotech, Inc. Panneaux multiples rapides de biomarqueurs des ait/avc dans des analyses sanguines en laboratoire
US20030199000A1 (en) 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040203083A1 (en) 2001-04-13 2004-10-14 Biosite, Inc. Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
DE60233949D1 (de) 2001-08-20 2009-11-19 Biosite Inc Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon
WO2003079884A2 (fr) 2002-03-19 2003-10-02 Children's Medical Center Corporation Methodes de diagnostic et de pronostic du cancer
US20040191783A1 (en) 2003-03-31 2004-09-30 Guy Leclercq Low density micro-array analysis in human breast cancer
EP2341350B1 (fr) 2003-09-20 2017-11-08 Electrophoretics Limited Methode de diagnostic de troubles associes a des lesions cerebrales basee sur la detection de dj-1
US7634360B2 (en) * 2003-09-23 2009-12-15 Prediction Sciences, LL Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
US8158362B2 (en) 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
US20060099608A1 (en) 2004-03-29 2006-05-11 Medstar Research Institute Methods of diagnosing cardiovascular disease
JP5697297B2 (ja) * 2004-05-14 2015-04-08 ロゼッタ ジノミクス リミテッド マイクロｎａｓおよびその使用
AU2005248410B2 (en) * 2004-05-27 2010-04-22 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Differential expression of molecules associated with acute stroke
DE102005048899A1 (de) 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Diagnose thromboembolischer Erkrankungen und koronarer Herzerkrankungen
ES2393758T3 (es) 2006-03-15 2012-12-27 Micronics, Inc. Ensayos integrados de ácidos nucleicos
EP2311981B1 (fr) 2007-05-01 2014-09-17 The Regents of The University of California Procédés de diagnostic d'ischémie
WO2010012834A1 (fr) 2008-08-01 2010-02-04 Bio-Rad Pasteur Méthode de diagnostic in vitro de l'accident vasculaire cérébral
AU2009246180B2 (en) 2008-05-14 2015-11-05 Dermtech International Diagnosis of melanoma and solar lentigo by nucleic acid analysis
CA2746120A1 (fr) 2008-12-23 2010-07-01 Genentech, Inc. Procedes et compositions pour une utilisation diagnostique chez les patients atteints de cancer
WO2011106322A2 (fr) 2010-02-23 2011-09-01 The Govt. Of The U.S.A. As Represented By The Secretary, Department Of Health And Human Services. Biomarqueurs pour accident ischémique cérébral aigu
CA2804763C (fr) 2010-07-14 2023-01-03 The Regents Of The University Of California Biomarqueurs utilises pour le diagnostic d'accidents ischemiques transitoires
CA2804802C (fr) 2010-07-15 2023-03-07 The Regents Of The University Of California Biomarqueurs utilises pour diagnostiquer un accident vasculaire cerebral et ses causes
US20120316076A1 (en) 2011-03-04 2012-12-13 The Regents Of The University Of California Biomarkers for the diagnosis of lacunar stroke
WO2013103781A1 (fr) 2012-01-07 2013-07-11 The Regents Of The University Of California Biomarqueurs permettant de diagnostiquer l'ischémie.

Also Published As

Publication number Publication date
CA2685382C (fr) 2023-02-21
EP2311981B1 (fr) 2014-09-17
CA2685382A1 (fr) 2008-11-13
US11421276B2 (en) 2022-08-23
US20100197518A1 (en) 2010-08-05
US20160222455A1 (en) 2016-08-04
US20200157624A1 (en) 2020-05-21
WO2008137465A1 (fr) 2008-11-13
CN101688245A (zh) 2010-03-31
EP2152907A1 (fr) 2010-02-17
EP2311981A1 (fr) 2011-04-20
CN101688245B (zh) 2013-09-25

Similar Documents

Publication Publication Date Title
HK1156368A1 (en) Methods for diagnosing ischemia
DK200800103A (en) Integreret føringskant for vindturbineblad
GB0706709D0 (en) Methods
ZA200905738B (en) Iron-hydrocarbon complex compounds
EP2206612A4 (fr) Pneu pour motocyclette
GB0718160D0 (en) Methods
GB0701574D0 (en) Wave-dissipating block
EP2185926A4 (fr) Procédé pour diagnostiquer l'ischémie cardiaque aiguë
TWM319832U (en) Improved structure for pliers
GB0701067D0 (en) Improved vehicles
GB2446009B (en) Improved vehicles
EP2134587A4 (fr) Agencement de barre intermédiaire de traction
GB0715502D0 (en) Methods
GB0714842D0 (en) Methods
GB0707735D0 (en) Methods
GB0719252D0 (en) Methods
GB0713673D0 (en) Methods
AU4471P (en) Rambudan Anigozanthos hybrid
AU4016P (en) Walhelivor Helleborus hybrid
AU3961P (en) Sunmandecrikin Mandevilla hybrid
AU3860P (en) REDGAPI Gaura hybrid
AU4473P (en) Rambubona Anigozanthos hybrid
AU4573P (en) Rambueleg Anigozanthos hybrid
AU3963P (en) Sunmanderemi Mandevilla hybrid
IL202584A0 (en) Methods for diagnosing hypersensitivity reactions